Mission: Our mission is to investigate the underlying causes of Alzheimer's and to develop rapid clinical interventions both for Alzheimer's and other brain disorders. A secondary mission is to promote public awareness and education with respect to Alzheimer's disease and related dementia, and to encourage the involvement of individuals, businesses, foundations, and government in finding a cure.
Results: NEAR is the only non-profit organization in the world to concentrate on developing gene transfer as a method of both modeling this disorder in the laboratory, as well as treating it in the clinic. By looking at the manner in which genes interact in Alzheimer's patients and also in unaffected people, we believe that new drug development and gene therapy will bring new cures and new hope for those suffering from Alzheimer's.
Target demographics: fight Alzheimer's disease
Direct beneficiaries per year: many people suffering with Alzheimer's disease
Geographic areas served: all states
Programs: research grants, informational sessions, and other support for Alzheimer's patients and their families.
My relative with Alzheimer's was told by her doctors that there is no hope. But NEAR is working on drug and gene therapies for the future, to keep hope alive.
NEAR rocks...it is totally awesome and I am a loyal donor. I'm excited to do my part to ensure that their work will continue for many years in the future.
My relative who got Alzheimer's is grateful for the hard work that NEAR has put into developing new gene therapies which some day will be a cure for her and many others. Thank you so much for your valuable work. You are truly saving lives and making a difference.
For me, the key in becoming involved in an organization is my sense of how they will help to change the world. In my opinion, this is one of the truly world-changing organizations and I am 100% behind NEAR in its mission to cure Alzheimer's by 2020.
NEAR is the world leader in gene therapy for Alzheimer's. Our generous donations of time and money will contribute toward a cure for Alzheimer's disease.
